[PRESS RELEASE] – AUSTIN, Texas, Oct. 9, 2025 – Texas Original, Texas’ leading medical cannabis provider, announced the launch of the state’s first oral syringe, available to patients starting this October. The 0.5-gram syringe offers an alternative to traditional gummies, giving providers more options to curate treatment plans with their patients. The product is the first new offering among Texas’ licensed dispensing organizations following the passage of House Bill 46, which expanded the approved methods of delivery under the Texas Compassionate Use Program (TCUP).
The syringe features Rick Simpson Oil (RSO), which is wholly derived from Texas Original’s proprietary Texas OG strain. RSO is a full-spectrum extract that includes all the cannabinoids, flavonoids, terpenes, proteins and other potentially beneficial compounds of the cannabis plant that may amplify the therapeutic benefits of THC.
“We committed to expanding access and diversifying our product line under the improved Texas Compassionate Use Program – the RSO syringe delivers on that promise and gives Texans even more choices for symptom relief,” Texas Original CEO Nico Richardson said. “This product also reflects our uncompromising focus on safety and quality. Texans deserve the best medical cannabis options available, and they can trust us to deliver them.”
The product is one of the new products available under H.B. 46, which drastically improved patient access throughout the state by:
- Adding new qualifying conditions, including conditions that cause chronic pain, Crohn’s disease, traumatic brain injury, or a terminal illness or condition for which a patient is receiving hospice or palliative care.
- Allowing for satellite locations where medicine can be stored, creating more availability for prescription pick-ups.
- Approving the use of aerosol or vapor as a means of administration. These medical products offer immediate relief, which is critical for patients with episodic conditions such as post-traumatic stress disorder (PTSD).
The launch comes as the company prepares to open its state-of-the-art headquarters in Bastrop. The 75,000-square-foot facility will feature expanded cultivation, testing and distribution.
"Opening our Bastrop facility isn't just about expansion; it's about what expansion makes possible," Richardson said. "The RSO syringe is just the beginning of what we can bring to market, faster and with even higher quality standards for Texas patients."
To learn more about whether you or a loved one qualifies for medical cannabis, visit the Texas Original website.
